Novocell Bio Co., Ltd. leads in technological competitiveness through ceaseless research and development.
이메일주소 무단수집을 거부합니다.
본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나 그 밖의 기술적 장치를 이용하여 무단으로 수집되는 것을 거부하며, 이를 위반시 정보통신망법에 의해 형사 처벌됨을 유념하시기 바랍니다.
Unlike T cells, which have a relatively slow immune response, NK cells self-identify malignant cells, transformed cells, or virus-infected abnormal cells, and directly attack and kill them.
It enhances the body's immunity by secreting chemokine and various cytokines, which are substances that play a role in inducing proliferation and activation of other immune cells.
It attacks even cancer cells that T cells cannot attack, and also removes cancer stem cells.
NK cells also play a role in transforming a ‘cold tumor’ that does not respond to anticancer drugs into a ‘hot tumor’ that responds sensitively.
There are no side effects compared to existing anticancer drugs, but a synergistic effect occurs when combined with anticancer treatment.
NK cells have already shown excellent anticancer effects through various clinical trials, and it can treat autoimmune diseases(rheumatoid arthritis, type 1 diabetes, atopy, psoriasis, hyperthyroidism, Crohn's disease, ulcerative colitis, Behçet's disease, Sjogren's syndrome, lupus, Lou Gehrig, etc.) & geriatric diseases(Parkinson's, Alzheimer's, degenerative brain diseases, etc.).
NK cells are leading the paradigm shift in modern medicine br
The size of the global autoimmune disease treatment market is also growing at an astonishing rate, and is expected to reach $23.86 billion by 2025.
[Global Autoimmune Drugs Market 2021-2025 TechNavio (Infiniti Research Ltd.) 2021.06